Feasibility of Essure Placement in Intrauterine Device Users

Mascaró, Marilina; Mariño, Monica; Vicens-Vidal, Margalida

doi:10.1016/j.jmig.2008.04.020

Cited by 17 publications

(7 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As a result, laparoscopic methods of tubal interruption became the preferred minimally invasive approach for permanent female sterilization 13 . Currently, there is a global consensus that the hysteroscopy approach is the ideal procedure for permanent contraception or family planning 14–19 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Transcervical hysteroscopic sterilization using cyanoacrylate: A long‐term experimental study on sheep

Bigolin¹,

Fagundes

Rivoire

et al. 2009

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

“…The contraceptive efficacy of hysteroscopic sterilization has been well documented 15–19 . New methods for hysteroscopic transcervical sterilization include the insertion of microinserts into the tubal ostia, causing proximal tubal occlusion.…”

Section: Discussionmentioning

confidence: 99%

Transcervical hysteroscopic sterilization using cyanoacrylate: A long‐term experimental study on sheep

Bigolin¹,

Fagundes

Rivoire

et al. 2009

J of Obstet and Gynaecol

View full text Add to dashboard Cite

show abstract

“…A few small retrospective feasibility studies elucidated the advantage to leave the IUD in place, but their outcomes were also less successful [6,7].…”

Section: Discussionmentioning

confidence: 99%

Hysteroscopic sterilization with Essure® device in situ: a challenge?

et al. 2010

View full text Add to dashboard Cite

Hysteroscopic sterilization through the Essure® method is preferably performed in the outpatient department without any form of anesthesia. This approach requires the hysteroscopic skills of the gynecologist to use the vaginoscopic route. Initially, the manufacturer advised to remove any type of intrauterine device (IUD), 1 month before the procedure, to prevent difficult procedures and also to increase the success rate of placement. This observational prospective study analyzed the outcome in women in where the IUD was left in the uterus during the sterilization. During a period of 2 years, all women have been included consecutively in seven public hospitals located in France and the Netherlands. During this procedure, 32 out of 239 IUDs had to be removed to finish the sterilization successfully. The placement success rate was 97%. Placement failures were not related to the IUD being present at the time of the procedure. At confirmation tests 3 months after insertion of the Essure®, only five tubes were still patent. No complications were registered. Pain was recorded, and women responded well on oral nonsteroidal anti-inflammatory drug medication. The IUD did not need to be removed before the start of the hysteroscopic sterilization; only in case the procedure could not be completed, the IUD had to be removed during the sterilization itself. Placement rate was 97.1%.

show abstract

“…Several studies included unilateral placement rates in women who had previous salpingectomies, 13,22,48 so these placement rates were omitted from the total denominators and numerators as necessary. Eight articles 9,10,17,19,25,26,30,56 only reported bilateral placement rates after more than one attempt. In these cases, the placement rate was recalculated using the data supplied in the article for the first attempt.…”

Section: Methodsmentioning

confidence: 99%

A Meta-Analysis of Bilateral Essure^® Procedural Placement Success Rates on First Attempt

Frietze

Leyser‐Whalen

Rahman

et al. 2015

Journal of Gynecologic Surgery

View full text Add to dashboard Cite

Background: The EssureÒ (Bayer HealthCare Pharmaceuticals, Leverkusen, Germany) female sterilization procedure entails using a hysteroscope to guide a microinsert into the Fallopian tube openings. Failed placement can lead to patient dissatisfaction, repeat procedures, unintended or ectopic pregnancy, perforation of internal organs, or need for subsequent medical interventions. Additional interventions increase women's health risks, and costs for patients and the health care industry. Demonstrated successful placement rates are 63%-100%. To date, there have not been any systematic analyses of variables associated with placement rates. Objectives: The aims of this review were: (1) to estimate the average rate of successful bilateral Essure microinsert placement on first attempt; and (2) to identify variables associated with successful placement. Materials and Methods: A meta-analysis was conducted on 64 published studies and 19 variables. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, all published studies between November 2001 and February 2015 were reviewed. The studies were taken from from PubMed and Google Scholar, and by using the the ''snowball'' method that reported variables associated with successful bilateral Essure placement rates. Results: The weighted average rate of successful bilateral microinsert placement on first attempt was 92% (0.92 [95% confidence interval: 0.904-0.931]). Variables associated with successful placements were: (1) newer device models; (2) higher body mass index; and (3) a higher percent of patients who received local anesthesia. Conclusions: The data gathered for this review indicate that the highest bilateral success rates may be obtained by utilizing the newest Essure device model with local anesthesia in heavier patients. More standardized data reporting in published Essure studies is recommended. ( J GYNECOL SURG 31:308)

show abstract

Feasibility of Essure Placement in Intrauterine Device Users

Cited by 17 publications

References 9 publications

Transcervical hysteroscopic sterilization using cyanoacrylate: A long‐term experimental study on sheep

Transcervical hysteroscopic sterilization using cyanoacrylate: A long‐term experimental study on sheep

Hysteroscopic sterilization with Essure® device in situ: a challenge?

A Meta-Analysis of Bilateral Essure^® Procedural Placement Success Rates on First Attempt

Contact Info

Product

Resources

About

Feasibility of Essure Placement in Intrauterine Device Users

Cited by 17 publications

References 9 publications

Transcervical hysteroscopic sterilization using cyanoacrylate: A long‐term experimental study on sheep

Transcervical hysteroscopic sterilization using cyanoacrylate: A long‐term experimental study on sheep

Hysteroscopic sterilization with Essure® device in situ: a challenge?

A Meta-Analysis of Bilateral Essure® Procedural Placement Success Rates on First Attempt

Contact Info

Product

Resources

About

A Meta-Analysis of Bilateral Essure^® Procedural Placement Success Rates on First Attempt